We have the expertise, support, and experience to deliver exceptional products, unbound.

Unbound Medicine and Tarius Launch 21 CFR Handheld

Regulations and Updated Federal Register now on PDAs and Wireless Devices

Charlottesville, VA and Albertslund, Denmark, November 16, 2005 — Today, Unbound Medicine, the leading provider of authoritative information designed for mobile professionals, and Tarius, the leading provider of global regulatory and compliance information for the pharmaceutical industry, announced the release of 21 CFR Handheld. Mobile regulatory professionals can now consult the complete Title 21 of the Code of the Federal Regulations (CFR) as well as Federal Register updates from any location using either a personal digital assistant (PDA) or a wireless device such as BlackBerry, Treo, or a Smartphone.

Regulatory and quality assurance professionals frequently consult current and relevant regulatory information to guide their decision making. Traditionally, these professionals carry a book of regulations with them and add notes manually whenever a change occurs. The book itself is only updated annually, so they must check regularly for updates and rely on their own notes in order to remain current.

For 21 CFR Handheld, Tarius inserts links that connect the user to amendments within hours of the daily release of new information by the U.S. Government Printing Office. Unbound Medicine’s unique platform delivers this daily update to 21 CFR Handheld users, either through PDA synchronization or over the Internet to a wireless device. Now regulatory professionals can always have the most up-to-date information in an integrated and portable format. .

“On-the-go pharmaceutical and regulatory professionals who need fast, authoritative answers to the constantly changing regulations that govern human drugs, biologics and medical devices will now be able to check the complete 21 CFR from any location, “ said Bill Detmer, MD, President and CEO of Unbound Medicine. “We are proud to partner with Tarius to serve this segment of the healthcare market, given their global reputation as a source of high quality information.”

“Unbound Medicine’s strength in information architecture and their versatile technology are a perfect complement to our capabilities at Tarius,” said Nina Lindholst, Vice President of Tarius. “Now our users can carry the essential 21 CFR in their pockets—complete with bi-directional links to the latest amendments.”

For more information about 21 CFR Handheld visit Unbound Medicine’s Online Catalog or CFR Handheld website.

About Tarius A/S
Tarius is the leading provider of global regulatory and compliance information for the pharmaceutical industry. Tarius continuously monitors information published by national authorities in more than 50 countries to provide companies in Europe and North America with online databases and customized, confidential intelligence solutions. Tarius is a wholly owned subsidiary of the Schultz Group, which was founded in 1661. Schultz is one of Denmark’s largest publishing houses and is Denmark’s Government Printing Office. Schultz serves professional customers with a broad array of databases, printed materials, web portals and subscription-based services in all legal fields. Additional information is available at www.tarius.com.

About Unbound Medicine
Unbound Medicine, Inc. develops next-generation knowledge management systems for healthcare. The company’s handheld, wireless and Web-based technology platform and information architecture services help partners provide clinicians, researchers, and other healthcare and regulatory professionals with advanced systems for acquiring, managing, and sharing knowledge. Additional information is available at www.unboundmedicine.com.


Questions about Unbound Medicine? Learn more.